WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ionis Pharmaceuticals earnings were -$327.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest IONS earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$92.5M, down 59.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IONS reported annual earnings of -$381.4M, with -16% growth.

IONS earnings history

Current Revenue
$1.1B
Current Earnings
-$327.0M
Current Profit Margin
-30.9%

IONS Return on Equity

Current Company
-58.6%
Current Industry
-141.9%
Current Market
13.5%
IONS's Return on Equity (-58.6%)... subscribe to Premium to read more.
High Return on Equity Performance

IONS Return on Assets

Current Company
-10.1%
Current Industry
-13.7%
IONS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IONS announces earnings.

IONS Return on Capital Employed

Current Company
-8.6%
Current Industry
-9.6%
IONS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IONS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IONS-$210.23M-$326.98MN/A-$2.01
CRNX-$489.18M-$496.39MN/A-$5.13
KYMR-$306.36M-$315.00MN/A-$3.58
PTGX-$112.47M-$114.71MN/A-$1.81
SYRE-$179.44M-$179.44MN/A-$2.12
View Top Biotech Stocks

Ionis Pharmaceuticals Earnings Reports & History FAQ

What were Ionis Pharmaceuticals's earnings last quarter?

On IONS's earnings call on May 6, 2026, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 2026 earnings per share (EPS) of -$0.56, up 39.78% year over year. Total IONS earnings for the quarter were -$92.53 million. In the same quarter last year, Ionis Pharmaceuticals's earnings per share (EPS) was -$0.93.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

Is Ionis Pharmaceuticals profitable or losing money?

As of the last Ionis Pharmaceuticals earnings report, Ionis Pharmaceuticals is currently losing money. Ionis Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$326.98 million, a 28.61% decrease year over year.

What was IONS's earnings growth in the past year?

As of Ionis Pharmaceuticals's earnings date in May 6, 2026, Ionis Pharmaceuticals's earnings has grown year over year. IONS earnings in the past year totalled -$326.98 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.